发病机制
炎症
医学
冲程(发动机)
生物信息学
免疫学
生物
机械工程
工程类
作者
Deepaneeta Sarmah,Aishika Datta,Swapnil Raut,Ankan Sarkar,Birva Shah,Mariya Bohra,Upasna Singh,Priya Jagtap,Falguni Baidya,Kiran Kalia,Xin Wang,Kunjan R. Dave,Dileep R. Yavagal,Pallab Bhattacharya
标识
DOI:10.2174/1381612826666200427084949
摘要
Inflammation is a devastating outcome of cerebrovascular diseases (CVD), namely stroke and atherosclerosis. Numerous studies over the decade have shown that inflammasomes play a role in mediating inflammatory reactions post cellular injury occurring after a stroke or a rupture of an atherosclerotic plaque. In view of this, targeting these inflammatory pathways using different pharmacological therapies may improve outcomes in patients with CVD. Here, we review the mechanisms by which inflammasomes drive the pathogenesis of stroke and atherosclerosis. Also, discussed here are the possible treatment strategies available for inhibiting inflammasomes or their up-stream/down-stream mediators.
科研通智能强力驱动
Strongly Powered by AbleSci AI